# International Flavors & Fragrances Inc. – Consensus ‘buy’ rating and 19.6% Upside Potential

- Link: https://www.directorstalkinterviews.com/international-flavors-fragrances-inc.consensus-buy-rating-and-19.6-upside-potential/4121126326
- Published: 2023-08-30T11:05:17+01:00
- Author: Charlotte Edwards

**International Flavors & Fragrances Inc.** which can be found using ticker (IFF)
have now 20 market analysts covering the stock. The analyst consensus now points
to a rating of ‘buy’. The target price High/Low ranges between 105 and 60 and has
a mean target at $79.41. Now with the previous closing price of $66.41 this indicates
there is a potential upside of 19.6%. Also worth taking note is the 50 day moving
average now sits at $75.79 and the 200 day moving average is $90.97. The company
has a market capitalization of 17.60B. The stock price for the company is currently
68.94 USD

 The potential market cap would be $21,041,845,598 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of 46.52 and
a 1.23% return on assets.

International Flavors & Fragrances Inc. is a creator and manufacturer of food, beverage,
health and biosciences, scent and pharma solutions and complementary adjacent products.
The Company’s segments include Nourish, Health & Biosciences, Scent and Pharma Solutions.
The Nourish segment comprises of ingredients, flavors and food designs, with a diversified
portfolio across natural and plant-based specialty food ingredients, flavor compounds,
and savory solutions and inclusions. The Health & Biosciences comprises of health,
cultures and food enzymes, home and personal care, animal nutrition and grain processing.
The Scent segment comprises of fragrance compounds, including fine fragrances and
consumer fragrances; fragrance ingredients, and cosmetic active ingredients. The
Pharma Solutions segment produces a portfolio that includes cellulosics and seaweed-
based pharmaceutical excipients, used to improve the functionality and delivery 
of active pharmaceutical ingredients.

Share on: